MedPath

Effectiveness of Extra corporal Shock Wave therapy in the treatment of Knee Arthritis

Phase 2
Conditions
Moderate knee osteoarthritis.
Gonarthrosis [arthrosis of knee]
Registration Number
IRCT201608044641N12
Lead Sponsor
Physical Medicine and Rehabilitation Research Center of Tabriz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

patients with moderate knee osteoarthritis grade 2 and 3, based on kellegren &Lawrence scale; patients at the age of 50-70 years.
Exclusion criteria: patients with rheumatologic disorders such as rheumatoid arthritis; past medical history of surgery on knee joints; past medical history of fracture in lower limbs with involvement of articular surface of knees; mild and sever knee osteoarthritis ( 1 and 4 radiological scale); patients with electrical implants such as pace makers; past medical history of conduction block cardiac disease; patients with epileptic disorders; patients with pregnancy; patients with deep vein thrombosis; past medical history of intra-articular injections since 6 month ago and systemic corticosteroid drugs consumption since 1 month ago; patients with balance disturbance; patients with neuropathy and sensory impairments; existence of any skin lesions around the knee joints; BMI above 30; patients who are unable to complete the questionnaire and procedures.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of Pain. Timepoint: Time zero(baseline), 3weeks later,7 weeks later. Method of measurement: Visual Analog Scale.
Secondary Outcome Measures
NameTimeMethod
Knee range of motin. Timepoint: Time zero (baseline),3weeks later,7 weeks later. Method of measurement: Goniometer.;Knee function. Timepoint: Time zero (baseline),3weeks later,7 weeks later. Method of measurement: WOMAC questionnaire.;HSCRP level. Timepoint: Time zero (baseline),final evaluation at week 7. Method of measurement: laberatory kit.
© Copyright 2025. All Rights Reserved by MedPath